Biosimilars, Volume 3, Issue (2013)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Biosimilars, Volume 3, Issue (2013)

See all volumes and issues
Vol 6, 2016 Vol 5, 2015 Vol 4, 2014 Volume 3, 2013 Vol 2, 2012 Vol 1, 2011
Download citations Download PDFs Download issue

Review

Review Article
Similar biotherapeutic products in Latin America. Regulation and opportunities for patients with autoimmune diseases
Zayrho Desanvicente-Celis, Julian Caro-Moreno, Mateo Enciso-Zuluaga & Juan-Manuel Anaya
Pages: 1-17
Published online: 04 Jan 2013
AbstractforSimilar biotherapeutic products in Latin America. Regulation and opportunities for patients with autoimmune diseases | References | PDF (710.6 KB)
  • 18 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Rituximab and biosimilars – equivalence and reciprocity
Zaina P Qureshi, Jametta S Magwood, Sarveshwari Singh & Charles L Bennett
Pages: 19-25
Published online: 14 Jun 2013
AbstractforRituximab and biosimilars – equivalence and reciprocity | References | PDF (141.1 KB)
  • 29 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Current and future biosimilars: potential practical applications in rheumatology
Ghaith Noaiseh & Larry Moreland
Pages: 27-33
Published online: 01 Aug 2013
AbstractforCurrent and future biosimilars: potential practical applications in rheumatology | References | PDF (192.2 KB)
  • 23 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Clinical efficacy and safety of SB309, a biosimilar recombinant human erythropoietin, in the management of anemia
Alaa Bagalagel, Abdulaziz Mohammed, Karen MacDonald & Ivo Abraham
Pages: 35-43
Published online: 21 Aug 2013
AbstractforClinical efficacy and safety of SB309, a biosimilar recombinant human erythropoietin, in the management of anemia | References | PDF (259.2 KB)
  • 12 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Clinical efficacy and safety of XM01, a biosimilar recombinant human erythropoietin, in the management of anemia
Abdulaziz Mohammed, Alaa Bagalagel, Karen MacDonald & Ivo Abraham
Pages: 45-53
Published online: 27 Aug 2013
AbstractforClinical efficacy and safety of XM01, a biosimilar recombinant human erythropoietin, in the management of anemia | References | PDF (242.5 KB)
  • 14 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Clinical efficacy and safety of Tevagrastim® (XM02), a biosimilar recombinant human granulocyte colony-stimulating factor
Alaa Bagalagel, Abdulaziz Mohammed, Karen MacDonald & Ivo Abraham
Pages: 55-62
Published online: 27 Aug 2013
AbstractforClinical efficacy and safety of Tevagrastim® (XM02), a biosimilar recombinant human granulocyte colony-stimulating factor | References | PDF (245.7 KB)
  • 17 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Physicochemical and biological comparison of the first Brazilian biosimilar filgrastim with its reference product
Monique Mantovani et al.
Article | Published online: 30 Aug 2016
Open Access
Adalimumab: a review of the reference product and biosimilars
Valderílio Feijó Azevedo et al.
Review Article | Published online: 26 Jul 2016
Open Access
"Step" versus "phase" in the clinical development of biosimilars: the correct noun holds the key to success
Reginald Ewesuedo
Published online: 22 Jun 2016
Open Access
Tools for the analysis and characterization of therapeutic protein species
Marceline Manka Fuh et al.
Review Article | Published online: 5 May 2016
Open Access